Literature DB >> 31688184

Zika Virus and the Rio Olympic Games.

Bruce Hamilton1,2, Dan Exeter1,3, Sarah Beable1,3, Lynne Coleman1,4, Chris Milne1,5.   

Abstract

OBJECTIVE: To evaluate the impact of Zika virus on preparation and management of the New Zealand (NZ) Olympic team.
DESIGN: Descriptive manuscript.
SETTING: New Zealand Olympic Health team preparation and management during the Rio de Janeiro Olympic Games, 2016. PATIENTS (OR PARTICIPANTS): New Zealand Olympic Team members. INTERVENTIONS (OR ASSESSMENT OF RISK FACTORS): This manuscript describes the approaches used by the NZ Olympic Health team to the minimization of risk from Zika virus. MAIN OUTCOME MEASURES: Although descriptive of approach forms most of the article, the results of Zika virus serology are presented.
RESULTS: The NZ Olympic Health team took a proactive approach to risk mitigation, including extensive education, clothing changes, mosquito spray, mosquito nets, and voluntary postexposure testing. No positive serology was observed in those tested.
CONCLUSIONS: The outbreak of Zika virus in Brazil, the associated complication of microcephaly, and the evolving understanding of virus transmission created significant uncertainty for NZ Olympic team members. The proactive approach taken by the health team to the mitigation of risk, combined with the anticipated low risk of arbovirus transmission over the period of the games, resulted in enhanced confidence from team members and no reports of positive serology.

Entities:  

Mesh:

Year:  2019        PMID: 31688184     DOI: 10.1097/JSM.0000000000000551

Source DB:  PubMed          Journal:  Clin J Sport Med        ISSN: 1050-642X            Impact factor:   3.638


  2 in total

Review 1.  The Tokyo Olympic Games and the Risk of COVID-19.

Authors:  Van Thuan Hoang; Jaffar A Al-Tawfiq; Philippe Gautret
Journal:  Curr Trop Med Rep       Date:  2020-10-30

Review 2.  Infectious Diseases and Mass Gatherings.

Authors:  Van-Thuan Hoang; Philippe Gautret
Journal:  Curr Infect Dis Rep       Date:  2018-08-28       Impact factor: 3.725

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.